The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects

Kate Faasse · Tim Cundy · Greg D. Gamble · Keith J. Petrie

96 citations0/0 files storedPsychosomatic Medicine

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Medication Adherence and Compliance Pain Management and Placebo Effect

Abstract

OBJECTIVE: Generic medications are associated with reduced perceived effectiveness, increased perceived adverse effects, and increased rates of nonadherence compared with brand-name medications. This study examined the effect of an apparent medication formulation change on subjective and objective measures of medication effectiveness and medication side effects. METHODS: Sixty-two university students participated in a study purportedly testing the effectiveness of fast-acting β-blocker medications in reducing preexamination anxiety. All tablets were placebos. In session 1, all participants received a yellow tablet ("Betaprol"). In session 2, participants were randomly allocated to receive Betaprol (no change condition) or a white tablet labeled either as "Novaprol" (branded change condition) or "Generic" (generic change condition). Blood pressure and state anxiety were measured before and after tablet ingestion. Side effects attributed to medication were assessed. RESULTS: The no change group showed significantly greater decreases in systolic blood pressure (mean [M] [standard deviation] = -7.72 mm Hg, standard error [SE] = 1.45) than the branded change (M = -2.75 mm Hg, SE = 1.44, p = .02) and generic change (M = -3.26 mm Hg, SE = 1.45, p = .03) groups. The no-change group showed significantly greater decreases in state anxiety (M = -1.53, SE = 0.33) than the branded change (M = -0.50, SE = 0.33, p = .03) and generic change (M = -0.52, SE = 0.33, p = .04) groups. Significantly more side effects were attributed to the medication in the generic change (M = 1.83, SE = 0.23) (but not the branded change) condition when compared with the no change condition (M = 0.87, SE = 0.31, p = .03). CONCLUSIONS: Medication formulation change, particularly to generic medication, seems to be associated with reduced subjective and objective measures of medication effectiveness and increased side effects.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 96 citations exist upstream.

References

1992The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)2005What do primary care patients think about generic drugs?2006Patients’ attitudes towards and experiences of generic drug substitution in Norway 2006Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland 2008Beliefs about generic drugs among elderly adults in hospital-based primary care practices 2010Longer is better 2011The Aging Consumer 2020Impact of Age on Brand Choice

Cited by

2019Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims 2015Generic versus brand-name drugs used in cardiovascular diseases

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.